Institutionalizing Telemedicine Applications: The Challenge of Legitimizing Decision-Making

被引:28
作者
Zanaboni, Paolo [1 ,2 ]
Lettieri, Emanuele [2 ]
机构
[1] Univ Hosp N Norway, Norwegian Ctr Integrated Care & Telemed, N-9038 Tromso, Norway
[2] Politecn Milan, Dept Management Econ & Ind Engn, I-20133 Milan, Italy
关键词
Telemedicine; decision making; institutionalization; technology assessment; implementation; program sustainability; HEALTH-CARE; INFORMATION-SYSTEMS; RANDOMIZED-TRIAL; SERVICES; PATIENT; COST; ACCOUNTABILITY; IMPLEMENTATION; TELEHEALTH; EMERGENCY;
D O I
10.2196/jmir.1669
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
During the last decades a variety of telemedicine applications have been trialed worldwide. However, telemedicine is still an example of major potential benefits that have not been fully attained. Health care regulators are still debating why institutionalizing telemedicine applications on a large scale has been so difficult and why health care professionals are often averse or indifferent to telemedicine applications, thus preventing them from becoming part of everyday clinical routines. We believe that the lack of consolidated procedures for supporting decision making by health care regulators is a major weakness. We aim to further the current debate on how to legitimize decision making about the institutionalization of telemedicine applications on a large scale. We discuss (1) three main requirements-rationality, fairness, and efficiency-that should underpin decision making so that the relevant stakeholders perceive them as being legitimate, and (2) the domains and criteria for comparing and assessing telemedicine applications-benefits and sustainability. According to these requirements and criteria, we illustrate a possible reference process for legitimate decision making about which telemedicine applications to implement on a large scale. This process adopts the health care regulators' perspective and is made up of 2 subsequent stages, in which a preliminary proposal and then a full proposal are reviewed.
引用
收藏
页数:11
相关论文
共 81 条
[71]   The legal and ethical aspects of telemedicine. 3: Telemedicine and malpractice [J].
Stanberry, B .
JOURNAL OF TELEMEDICINE AND TELECARE, 1998, 4 (02) :72-79
[72]   MANAGING LEGITIMACY - STRATEGIC AND INSTITUTIONAL APPROACHES [J].
SUCHMAN, MC .
ACADEMY OF MANAGEMENT REVIEW, 1995, 20 (03) :571-610
[73]  
Suri JS, 2005, ST HEAL T, V114, P140
[74]   Association of Telemedicine for Remote Monitoring of Intensive Care Patients With Mortality, Complications, and Length of Stay [J].
Thomas, Eric J. ;
Lucke, Joseph F. ;
Wueste, Laura ;
Weavind, Lisa ;
Patel, Bela .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (24) :2671-2678
[75]  
Tobman M, 2002, ST HEAL T, V90, P152
[76]   The TeleGuard trial of additional telemedicine care in CAD patients. 2 morbidity and mortality after 12 months [J].
Waldmann, Annika ;
Katalinic, Alexander ;
Schwaab, Bernhard ;
Richard, Gert ;
Sheikhzadeh, Abdolhamid ;
Raspe, Heiner .
JOURNAL OF TELEMEDICINE AND TELECARE, 2008, 14 (01) :22-26
[77]   Patient and clinician satisfaction with a store-and-forward teledermatology consult system [J].
Whited, JD ;
Hall, RP ;
Foy, ME ;
Marbrey, LE ;
Grambow, SC ;
Dudley, TK ;
Datta, SK ;
Simel, DL ;
Oddone, EZ .
TELEMEDICINE JOURNAL AND E-HEALTH, 2004, 10 (04) :422-431
[78]   Keys to a successful and sustainable telemedicine program [J].
Whitten, Pamela ;
Holtz, Bree ;
Nguyen, Lianh .
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2010, 26 (02) :211-216
[79]   Multicentre randomised control trial comparing real time teledermatology with conventional outpatient dermatological care: societal cost-benefit analysis [J].
Wootton, R ;
Bloomer, SE ;
Corbett, R ;
Eedy, DJ ;
Hicks, N ;
Lotery, HE ;
Mathews, C ;
Paisley, J ;
Steele, K ;
Loane, MA .
BRITISH MEDICAL JOURNAL, 2000, 320 (7244) :1252-1256
[80]  
Wootton R., 2006, Introduction to Telemedicine, V2nd